LEGN

Legend Biotech Corporation American Depositary Shares
Data: 2026-01-30
$17.5
Price
-1.92%
Change
$45.2972
52W High
$17.03
52W Low

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Quick Stats
Jan 30, 2026

45.8

AI Score

HOLD

1.17

Volume Ratio

Mar 10, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

LEGN Stock Summary

Last updated Jan 30, 2026

LEGN is currently trading at $17.5, positioned below its 200-day moving average of $31.53, suggesting bearish momentum. The stock has a 52-week range of $17.03 to $45.2972.

Technical Analysis: The 50-day moving average stands at $23.27, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.486, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.178, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LEGN at 45.8/100 with a HOLD recommendation.

LEGN (Legend Biotech Corporation American Depositary Shares) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 28.486
CMF (20) -0.178
ROC (10) -20.85
ADX (14) 32.109
Indicator Value
MACD (12,26,9) -1.607
AROONOSC (14) -100.0
WILLAMS %R (14) -93.237
MFI (14) 16.351
LEGN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LEGN Price vs Max Options Open Interest
LEGN Max Change In Options Open Interest

LEGN Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LEGN Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LEGN Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

LEGN Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Legend Biotech Corporation American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

LEGN Moving Averages Analysis

LEGN (Legend Biotech Corporation American Depositary Shares) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 19.48
20 20.93
30 21.31
50 23.27
100 27.91
200 31.53

LEGN Fundamental Analysis

P/E (Forward) 48.3092
P/E (Trailing) --
Market Cap ($) 3.3 billion
Earnings/Share ($) -1.28
Net Proft Margin (%) -0.2637
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.4072
EPS Estimate Next Year ($) 0.252
WallStreet Target Price ($) 66.3212
Most Recent Quarter